This post was originally published on this site
Best Buy Co Inc (NYSE:BBY) shares fell more than 3% today after BofA Securities downgraded the company to Underperform from Neutral and lowered its price target to $69 from $80. The analysts expect a challenging environment for the company to achieve earnings growth in both the near term and the medium term.
Chardan Capital Markets downgraded Moderna (NASDAQ:MRNA) to Neutral from Buy with a price target of $191.00, citing swollen valuation, while the market was evidently enthusiastic about the Phase 2b results. Shares gained another 5% today adding to yesterday’s nearly 20% after the company’s mRNA cancer vaccine, developed together with Merck & Company Inc (NYSE:MRK), met the primary efficacy endpoint in Phase 2b trials.
Exane BNP Paribas downgraded Chevron (NYSE:CVX) to Underperform from Neutral with a price target of $190.00.
Want to get this news first? Upgrade to InvestingPro for real-time market coverage.
